ZT
The startup develops a subcutaneous injection drug therapy that prevents hypoglycemia in individuals with diabetes. This therapy aims to reduce the morbidity and mortality associated with hypoglycemic events, thereby enhancing diabetes management and improving patient health outcomes.
Updated 3 months ago
Funding
$45.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SFunding rounds are not available yet.
Founders
Product
Features
- The startup develops a subcutaneous injection drug therapy that prevents hypoglycemia in individuals with diabetes. This therapy aims to reduce the morbidity and mortality associated with hypoglycemic events, thereby enhancing diabetes management and improving patient health outcomes.